Original Research

A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agents

El Sagheer GM, Ahmad AK, Abd-ElFattah AS, Saad ZM, Hamdi L

Clinical and Experimental Gastroenterology 2018, 11:415-422

Published Date: 24 October 2018